Nanotechnology/Nanomedicines in Cancer Treatment

The application of nanotechnology to cancer treatment has some exciting potential consequences, including the possibility of eliminating cancerous tumours with little injury to healthy tissue and organs and the identification and removal of sick cells before they form tumours. Focused chemotherapy, which delivers a tumor-executing agent called tumour rot factor alpha (TNF) to developing tumours, is one form of treatment under investigation. TNF is attached to a gold nanoparticle together with Thiol-derivatized polyethylene glycol (PEG-THIOL), which hides the TNF-bearing nanoparticle from the resistant framework. This enables the nanoparticle to pass through the circulatory system unharmed.Delivering or Augmenting Radiotherapy.

  • Delivering Chemotherapy
  • Nano-enabled Immunotherapy

Related Conference of Nanotechnology/Nanomedicines in Cancer Treatment

December 14-15, 2023

5th International Conference on Oncology and Cancer

Rome, Italy
February 22-23, 2024

14th World Congress on Breast Cancer

Zurich, Switzerland
March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
March 21-22, 2024

8th Global Meeting on Oncology and Radiology

Paris, France
April 18-19, 2024

24th World Congress on Cancer and Diagnostics

Dubai, UAE

Nanotechnology/Nanomedicines in Cancer Treatment Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in